The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins

We describe the importance of this topic and explain key assumptions necessary for the investigators to arrive at their conclusions.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Commentary Source Type: research